stoxline Quote Chart Rank Option Currency Glossary
  
Progyny, Inc. (PGNY)
22.36  0.41 (1.87%)    02-14 16:00
Open: 22.06
High: 22.55
Volume: 952,816
  
Pre. Close: 21.95
Low: 21.92
Market Cap: 1,904(M)
Technical analysis
2025-02-14 4:50:34 PM
Short term     
Mid term     
Targets 6-month :  27.81 1-year :  32.48
Resists First :  23.8 Second :  27.81
Pivot price 22.67
Supports First :  20.71 Second :  18.8
MAs MA(5) :  22.21 MA(20) :  22.48
MA(100) :  17.37 MA(250) :  24.47
MACD MACD :  0.8 Signal :  1.1
%K %D K(14,3) :  24.4 D(3) :  30.7
RSI RSI(14): 60.4
52-week High :  40.88 Low :  13.39
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PGNY ] has closed above bottom band by 38.4%. Bollinger Bands are 41.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 22.57 - 22.68 22.68 - 22.8
Low: 21.66 - 21.77 21.77 - 21.89
Close: 22.17 - 22.36 22.36 - 22.54
Company Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Headline News

Sat, 15 Feb 2025
PGNY - Progyny, Inc. Latest Stock News & Market Updates - StockTitan

Thu, 13 Feb 2025
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report - GlobeNewswire

Thu, 13 Feb 2025
Earnings Alert: Progyny Sets Date for 2024 Annual Results - Key Details for Investors - StockTitan

Sun, 09 Feb 2025
Vanderbilt University Purchases Shares of 14,730 Progyny, Inc. (NASDAQ:PGNY) - MarketBeat

Tue, 28 Jan 2025
Game-Changing Parental Benefits Deal: Progyny Just Solved Working Parents' Biggest Challenge - StockTitan

Tue, 28 Jan 2025
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 85 (M)
Shares Float 73 (M)
Held by Insiders 7.3 (%)
Held by Institutions 108 (%)
Shares Short 11,530 (K)
Shares Short P.Month 12,200 (K)
Stock Financials
EPS 0.6
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.92
Profit Margin 5 %
Operating Margin 4.3 %
Return on Assets (ttm) 5.9 %
Return on Equity (ttm) 12 %
Qtrly Rev. Growth 2 %
Gross Profit (p.s.) 2.89
Sales Per Share 13.38
EBITDA (p.s.) 0.8
Qtrly Earnings Growth -31.3 %
Operating Cash Flow 165 (M)
Levered Free Cash Flow 145 (M)
Stock Valuations
PE Ratio 37.26
PEG Ratio 0
Price to Book value 4.54
Price to Sales 1.67
Price to Cash Flow 11.56
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android